Similar for CRXM the company Olaregen/Generex got Excellagen from and will owe royalries to if things work out.

Many of these companies are struggling to move forward due to financing and covid.

It is kind of a vicious cycle, especially for the companies tied to covid research/business. Worse with the small OTC companies struggling for financing.

Now you have predatory lenders getting skittish because of increased scrutinty by the SEC/DOJ thanks to the John Fife's of the world.